NEW YORK (GenomeWeb News) — Helicos BioSciences has begun manufacturing its Heliscope genome sequencer at its facility in Cambridge, Mass., the company said this week.
 
The company also said it is “approach[ing] receipt of our first commercial order.” It did not elaborate.
 
The company, which began trading on the Nasdaq exchange late last month, said it is expecting to launch the Heliscope late this year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.